newsfilter
← Latest News
PR Newswire·

Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting

JERUSALEM, Sept. 20, 2021 /PRNewswire/ -- Dr. Morris C. Laster today announced that he has filed preliminary proxy materials with the Securities and Exchange Commission ("SEC") in connection with the 2021 Annual Meeting of Stockholders ("Annual Meeting"